These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 15315007
1. Plasma activity of interleukin-10 in drug-induced cutaneous reactions. Chodorowska G, Czelej D, Krasowska D, Pietrzak A. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):317-21. PubMed ID: 15315007 [Abstract] [Full Text] [Related]
2. Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions. Chodorowska G, Czelej D, Niewiedzioł M. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):7-13. PubMed ID: 15323158 [Abstract] [Full Text] [Related]
3. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions. Chodorowska G, Czelej D, Niewiedzioł M. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166 [Abstract] [Full Text] [Related]
4. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma. Chodorowska G, Czelej D. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957 [Abstract] [Full Text] [Related]
5. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421 [Abstract] [Full Text] [Related]
6. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma. Czelej D, Chodorowska G, Lechowska-Mazur I. Ann Univ Mariae Curie Sklodowska Med; 2003 Oct; 58(1):38-42. PubMed ID: 15314956 [Abstract] [Full Text] [Related]
7. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology. Quaglino P, Caproni M, Antiga E, Del Bianco E, Osella-Abate S, Savoia P, Frezzolini A, Schena D, Marzano A, Volpi W, De Simone C, Parodi A, Fabbri P, Bernengo MG, Italian Group of Immunopathology. Dermatology; 2007 Oct; 214(4):296-304. PubMed ID: 17460400 [Abstract] [Full Text] [Related]
8. Plasma activity of interleukin-6 and some acute phase proteins in severe drug-induced skin adverse reactions. Czelej D, Chodorowska G, Lecewicz-Toruń B. Ann Univ Mariae Curie Sklodowska Med; 2002 Oct; 57(2):62-7. PubMed ID: 12898820 [Abstract] [Full Text] [Related]
9. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803 [Abstract] [Full Text] [Related]
10. Interleukin-6 and some acute phase proteins plasma activity in drug-induced maculopapular eruptions. Chodorowska G, Czelej D, Roguś-Skorupska D. Ann Univ Mariae Curie Sklodowska Med; 2004 Feb; 59(1):180-4. PubMed ID: 16145976 [Abstract] [Full Text] [Related]
11. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. Gau SS, Chao PF, Lin YJ, Chang CJ, Gau CS. J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645 [Abstract] [Full Text] [Related]
13. T cell populations propagating in the peripheral blood of patients with drug eruptions. Nishio D, Izu K, Kabashima K, Tokura Y. J Dermatol Sci; 2007 Oct; 48(1):25-33. PubMed ID: 17601705 [Abstract] [Full Text] [Related]
14. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Morel E, Alvarez L, Cabañas R, Fiandor A, Díaz R, Escamochero S, Prior N, Blanca M, Bellón T. Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148 [Abstract] [Full Text] [Related]
15. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Arch Dermatol; 1995 May; 131(5):539-43. PubMed ID: 7741539 [Abstract] [Full Text] [Related]
16. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. Murata J, Abe R, Shimizu H. J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887 [Abstract] [Full Text] [Related]
17. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis. Hung CC, Liu WC, Kuo MC, Lee CH, Hwang SJ, Chen HC. Am J Nephrol; 2009 Nov; 29(6):633-8. PubMed ID: 19155617 [Abstract] [Full Text] [Related]
18. [Skin and hair]. Briner VA. Schweiz Med Wochenschr; 1996 Apr 06; 126(14):549-58. PubMed ID: 8668968 [Abstract] [Full Text] [Related]
19. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity. Morsy H, Taha EA, Nigm DA, Shahin R, Youssef EMK. Clin Exp Dermatol; 2017 Dec 06; 42(8):868-873. PubMed ID: 28940568 [Abstract] [Full Text] [Related]
20. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W. Pharmacogenet Genomics; 2009 Sep 06; 19(9):704-9. PubMed ID: 19696695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]